Startup | November 18, 2021
Illumina and Sequoia Capital China selects startups for Genomics
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
Subscribe To Our Newsletter & Stay Updated
